/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Agreement Express and Paya Services Launch Unified Application for Merchant Acquisition
Reading Time: 4 minutes
Payroc First to Market with Unified Application Solution for
Merchants
TORONTO, ATLANTA & TINLEY PARK, Ill.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/AgreementExpress?src=hash” target=”_blank”gt;#AgreementExpresslt;/agt;–Agreement
Express, the leading provider of total digital onboarding for
payment service and wealth management providers, today announced the
availability of Paya Services check and ACH offerings on the Agreement
Express Unified Application. The integration allows independent sales
organizations and independent software vendors to offer Paya Services
check and ACH products digitally with a unified digital application on
the Agreement Express platform, enabling them to increase the revenue
per client with a faster and more efficient digital workflow.
Payroc, a leading payment service provider with nearly $10 billion in
annual processing volume, has signed on as an early adopter. They will
be first to market with the new combined solution, providing both agents
and merchants with a simpler, more efficient application process. “Our
partners asked for a simpler way to enroll businesses to accept
electronic payments, so we partnered with Agreement Express to create
the simplest application possible,” says Ryan Hallett, chief revenue
officer for Payroc. “With the connection to Paya Services, our merchants
will only have to fill out one application to access all of our
offerings, plus with technology and automation in onboarding and data
security, our Payroc payment professionals, ISOs and ISV partners will
have more time to cultivate new relationships.”
Beyond digital forms and e-signatures, Agreement Express delivers the
tools ISOs and ISVs need to offer clients a simple customer onboarding
experience, moving applications and transactions through appropriate
workflows with robotic process automation, automated know your customer
and anti-money laundering due diligence, risk and underwriting
decisioning, and robust compliance controls on the back end. The result
is a simplified experience for merchants, and faster time to revenue for
ISOs and ISVs.
Paya Services’ check and ACH application is integrated into the
Agreement Express Unified Application, allowing merchants to sign up for
acquiring and ACH payments acceptance products with one, unified,
digital application and approval process. Offering more products
increases an ISO or acquirer’s processing volume, decreases portfolio
churn and increases competitiveness in the rapidly changing payments
industry.
With the release of Unified Application, ISOs and ISVs can now offer a
unified onboarding experience that includes the following Paya Services
merchant offerings:
-
POS Conversion (POP) – Safely accept and process checks electronically
at the point of sale with a check reader or an imager -
Check 21 – Accept all types of checks in a face-to-face or
consumer-not-present environment, using front and back check image as
a replacement -
Checks by Web (WEB) – Accept consumer-initiated payments online for
bill pay or e-commerce - Checks by Phone (TEL) – Accept and process checks over the phone
-
ACH Debit and Credit (PPD / CCD) – Process single or recurring ACH
transactions from consumer or business accounts
Tangible ISO and ISV benefits include:
- Faster time to revenue with digital application, workflow, and approval
-
Ability to increase transactions with a unified application for
multiple offerings - Optimized, best-in-class experience for digital payment acceptance
-
Simplified risk management with intelligent applications with
integrated compliance controls
“We are working with Paya Services to provide their partners with
elegant digital experiences,” said Peter Fitzpatrick, vice president
payments for Agreement Express. “As an early adopter, Payroc will use
our Unified Application technology to offer a truly simple enrollment
process, providing their partners and merchants with a single, digital
application for both acquiring products and ACH services.”
Representatives from Agreement Express, Paya Services and Payroc will
attend this week’s Electronic Transactions Association’s TRANSACT
19 conference at the Mandalay Bay Convention Center in Las Vegas.
Visit Paya Services at booth #2612 and Payroc at booth #3616 to learn
more.
About Agreement Express
Agreement
Express is the only complete client onboarding platform for
financial services. The Agreement Express platform allows financial
institutions to design and execute consistent automated onboarding
experiences across their product offerings and channels, while providing
deep analytics that enable proactive and personalized client advice. The
platform is the first of its kind to help top performing firms gather,
use, and reuse client data to improve and evolve rich customer
experiences. Agreement Express enables Fortune 500 financial
institutions around the world to provide best-in-class digital
onboarding to their clients and grow their business. For more
information about Agreement Express, visit agreementexpress.com
or connect with us on Twitter
or LinkedIn.
About Paya Services
Paya Services provides merchants with payment solutions to help them get
paid faster, increase efficiency and boost customer loyalty through our
check processing, ACH processing and gift and loyalty card programs. Our
seamless payments platform delivers easy-to-use technology to support
every stage of business growth, today and tomorrow. For more information
about Paya Services, visit paya.com
or connect with us on Twitter
or LinkedIn.
About Payroc, LLC
Payroc, headquartered in the Tinley Park suburb of Chicago, drives
commerce for its merchants with anytime, anywhere payment solutions.
Payroc serves its referral partners and merchant clients with integrity
as trusted advisors and recognized experts in payments, providing
transparent pricing clarity, and developing personal relationships while
delivering exceptional technology. Payroc services and supports more
than 30,000 merchants throughout North America, providing stability in
payments by safely and securely processing over $10 billion in annual
charge volume. The company is a full-service merchant acquirer, a
registered ISO of MB Financial Bank, N.A., Chicago, Illinois, a
registered ISO and payment facilitator of Fifth Third Bank, Cincinnati,
Ohio, and a registered ISO of Wells Fargo, Concord, California. For more
information, please visit payroc.com
or telephone 844-PAYROC-4 or follow us on Twitter
or LinkedIn.
Contacts
Media Contact:
Aaron Davis
Vice President, Marketing
Agreement
Express
[email protected]
416-616-1362
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the seller.
“With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential,” said Oren Shuster, CEO of IMC. “With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment.”
About IM Cannabis Corp.
IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.
The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC’s products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.
Disclaimer for Forward-Looking Statements
This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, the occurrence of growth opportunities and the likelihood of growth potential.
Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the development and introduction of new products; continuing demand for medical and adult-use recreational cannabis in the markets in which the Company operates; the Company’s ability to reach patients through both e-commerce and brick and mortar retail operations; the Company’s ability to maintain and renew or obtain required licenses; the effectiveness of its products for medical cannabis patients and recreational consumers; and the Company’s ability to market its brands and services successfully to its anticipated customers and medical cannabis patients.
The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward looking statements due to a number of factors and risks. These include: any failure of the Company to maintain “de facto” control over Focus Medical in accordance with IFRS 10; the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the effect of the reform on the Company; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group”) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East
Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.
The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
Company Contacts:
Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]
Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
[email protected]
Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller-302117984.html
-
Avant2 weeks agoAvant and IMC Execute BLK MKT™ Trademark Licensing Agreement for the German Medical Cannabis Market
-
StickIt1 week agoStickIt Technologies Inc. Announces Year-End 2023 Financial Results
-
Cannabis1 week ago
Hemp, Inc. Welcomes USDA Approval of GMO Hemp Strain – A Step Forward in Cannabis Biotechnology
-
Cannabis1 week ago
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
-
Cannabis1 week agoAvicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
-
Cannabis1 week ago
Right On Brands, Inc. Continues Rollout, Announces 13th Store Opening
-
Cannabis1 week ago
Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results
-
Cannabis1 week ago
Geopulse Exploration, Inc. Acquires 50% of ATC Services
